Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.307,59
-1,93%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gossamer Bio Inc (GOSS) Gossamer Bio Inc (GOSS) Notizie

Gossamer Bio Inc

GOSS
0,8548
0,0013 (0,15%)
28 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202422:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
11/11/202422:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/11/202422:03BWGossamer Bio Announces Third Quarter 2024 Financial Results..
07/11/202422:02EDGAR2Form 8-K - Current report
07/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/10/202423:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
13/9/202422:01EDGAR2Form 8-K - Current report
26/8/202422:01BWGossamer Bio Announces Data Presentations at the European..
12/8/202422:02EDGAR2Form 8-K - Current report
12/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:01BWGossamer Bio Announces Second Quarter 2024 Financial Results..
03/8/202400:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
18/7/202422:01EDGAR2Form 8-K - Current report
10/6/202422:01EDGAR2Form 8-K - Current report
07/6/202422:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/6/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:01BWGossamer Bio to Provide Updated Seralutinib TORREY..
10/5/202422:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/5/202422:02EDGAR2Form 8-K - Current report
07/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:01BWGossamer Bio Announces First Quarter 2024 Financial Results..
06/5/202413:31EDGAR2Form 8-K - Current report
06/5/202413:30BWGossamer Bio and Chiesi Group Announce Transformative Global..
03/5/202414:02BWGossamer Bio Announces Publication of TORREY Phase 2 Results..
12/3/202412:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
05/3/202413:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:31EDGAR2Form 8-K - Current report
05/3/202413:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
04/3/202422:02EDGAR2Form 8-K - Current report
08/1/202422:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
04/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,8532 Min: 0,8237 Max: 0,8725
Chiusura: 0,8535

La tua Cronologia

NASDAQ
GOSS
Gossamer Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network